Open Access

Revista Española de Medicina Nuclear e Imagen Molecular offers authors two choices to publish their research:

In accordance with funding body requirements, Elsevier offers alternative open access publishing options. Visit our open access page for full information.

Your publication choice will have no effect on the peer review process or acceptance of your submission.

All articles published gold open access will be immediately and permanently free for everyone to read and download, copy and distribute. We offer authors a choice of user licenses, which define the permitted reuse of articles. We currently offer the following license(s) for this journal:

Allows users to: distribute and copy the article; create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); includes a link to the license; indicates if changes were made; and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.

Allows users to: distribute and copy the article; and include in a collective work (such as an anthology). These uses are permitted only for non-commercial purposes, and provided the user: gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); provides a link to the license; and does not alter or modify the article.

If you need to comply with your funding body policy you can apply for a CC BY license after your manuscript is accepted for publication.

To provide gold open access, this journal has a publication fee (Article Publishing Charge, APC) which needs to be met by the authors, or their institution or funders, for each article published open access. This ensures your article will be immediately and permanently free to access by everyone.

The Article Publishing Charge for this journal is:

Our Online Author Communication System (OACS) ensures you are offered the lowest possible Article Publishing Charge to publish an article in your chosen journal. During submission you will be presented with a personalized OA Article Publishing Charge based on your individual context (your country, institutional affiliation, and any society membership for example) as well as considering the journal involved.

Learn more about Elsevier's pricing policy.

Elsevier has reached open access agreements with an increasing number of institutions and university consortia around the world. Find out what this means for authors on our open access agreements page.

Elsevier partners with funding bodies to provide guidance for authors on how to comply with funding body open access policies. Find out more on our funding arrangements page.

Authors can share their subscription research in a variety of ways. When publishing under the subscription model, an author can self-archive their accepted manuscript immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. The embargo period for this journal can be found below.

The published journal article cannot be shared publicly, for example on ResearchGate or Academia.edu, to ensure the sustainability of peer-reviewed research in journal publications.

For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before a manuscript becomes available for free to the public. This is called an embargo period and it begins from the date the article is formally published online in its final and fully citable form. 

This journal has an embargo period of 12 months.

Find out how you can share your research published in Elsevier journals.

• Benefits of publishing open access with Elsevier

• Open access agreements

• Funding arrangements

• Open access license policy

• Open access pricing policy

Frequently asked questions and answers are available in the Journal Article Publishing Support Center.

Please contact [email protected] for any further questions.